Patent · US Active

Method for the eradication of pathogens including S. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells

US8303994B2 · kind B2 · utility

4Cited by
8References
9Claims
0Family size

Inventors

Key dates

Filing dateJun 22, 2006
Grant dateNov 6, 2012
Priority date
Expiry dateAug 14, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P37/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for killing or substantially eradicating a pathogen in the upper respiratory tract of a mammal is disclosed. The method comprises generating molecular iodine (I2) in situ using an oxidant-reductant reaction with a minimum concentration of at least about 25 ppm of I2 and I2 comprises at least 40% of the total iodine atoms. A method for inhibiting superantigens using molecular iodine is also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.